Nevada Cancer Research Foundation
Carson-Tahoe Hospital
TREATMENT PROTOCOLS
![]()
| BRAIN | |
| BREAST | |
| GASTROINTESTINAL | |
| GENITOURINARY | |
| GYNECOLOGICAL | |
| HEAD AND NECK | |
| LEUKEMIA | |
| LYMPHOMA | |
| LUNG |
![]()
| 0614 - A RANDOMIZED, PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MEMANTINE FOR PREVENTION OF COGNATIVE DYSFUNCTION IN PATIENTS RECEIVING WHOLE-BRAIN RADIOTHERAPY |
![]()
ADJUVANT
| B-39/0413
- A
Randomized Phase | |
| pacct-1 - Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial |
METASTATIC
| S0500 - A RANDOMIZED PHASE III TRIAL TO TEST THE STRATEGY OF CHANGING THERAPY VERSUS MAINTAINING THERAPY FOR METASTATIC BREAST CANCER PATIENTS WHO HAVE ELEVATED CIRCULATING TUMOR CELL LEVELS AT FIRST FOLLOW-UP ASSESSMENT |
![]()
ANAL CANAL
COLORECTAL
COLON
| E5202 - A RANDOMIZED PHASE III STUDY COMPARING 5-FU, LEUCOVORIN AND OXALIPLATIN VERSUS 5-FU, LEUCOVORIN, OXALIPLATIN AND BEVACIZUMAB IN PATIENTS WITH STAGE II COLON CANCER AT HIGH RISK FOR RECURRENCE TO DETERMINE PROSPECTIVELY THE PROGNOSTIC VALUE OF MOLECULAR MARKERS |
![]()
RENAL
| E2805 - A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma |
PROSTATE
| |
![]()
CERVICAL
![]()
![]()
| 10501 - A PHASE III INTERGROUP CLL STUDY OF ASYMPTOMATIC PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RANDOMIZED TO EARLY INTERVENTION VERSUS OBSERVATION WITH LATER TREATMENT IN THE HIGH RISK GENETIC SUBSET WITH IgVH UNMUTATED |
![]()
NON-HODGKIN'S
| E4402 - RANDOMIZED PHASE III TRIAL COMPARING TWO DIFFERENT RITUXIMAB DOSING REGIMENS FOR PATIENTS WITH LOW TUMOR BURDEN INDOLENT NON-HODGKIN'S LYMPHOMA |
![]()
NON-SMALL CELL
SMALL CELL
|
|
![]()